Healthequity Net Cash Flow or Change in Cash and Cash Equivalents Over Time

HQY
 Stock
  

USD 60.65  0.10  0.16%   

With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Please check Healthequity Performance and Healthequity Correlation.
  
Net Cash Flow or Change in Cash and Cash Equivalents is likely to drop to about (106.1 M) in 2022. Free Cash Flow is likely to drop to about 65.6 M in 2022.

Healthequity Quarterly Net Cash Flow or Change in Cash and Cash Equivalents

(64.17 Million)

Is Healthequity's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Healthequity. If investors know Healthequity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Healthequity listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
-0.96
Market Capitalization
5.2 B
Quarterly Revenue Growth YOY
0.12
Return On Assets
0.0059
Return On Equity
-0.0299
The market value of Healthequity is measured differently than its book value, which is the value of Healthequity that is recorded on the company's balance sheet. Investors also form their own opinion of Healthequity's value that differs from its market value or its book value, called intrinsic value, which is Healthequity's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Healthequity's market value can be influenced by many factors that don't directly affect Healthequity's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Healthequity's value and its price as these two are different measures arrived at by different means. Investors typically determine Healthequity value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Healthequity's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Specify up to 10 symbols:

Cross Equities Net Cash Flow or Change in Cash and Cash Equivalents Analysis

Compare Healthequity and related stocks such as La-Z-Boy, Chevron Corp, Home Depot, JP Morgan Chase, 3M Company, Verizon Communications, Caterpillar, Pfizer Inc, and Alcoa Corp Net Cash Flow or Change in Cash and Cash Equivalents Over Time
Select Fundamental

2010201120122013201420152016201720182019202020212022
LZB131.2 M131.2 M131.2 M131.2 M131.2 M131.2 M131.2 M131.2 M131.2 M131.2 M131.2 M(145.8 M)(149.7 M)
CVX1.8 B1.8 B5.1 B(4.7 B)(3.5 B)(1.8 B)(3.7 B)(2.5 B)4.5 B(3.6 B)(174 M)58 M62.6 M
HD(100 M)(100 M)(100 M)(100 M)(100 M)236 M236 M236 M236 M236 M(5.5 B)(5.5 B)88.4 M
JPM32 B32 B(5.9 B)(14 B)(11.9 B)(7.3 B)29.5 B40.1 B(152.5 B)(15.2 B)264 B213.2 B230.1 B
MMM(1.2 B)(1.2 B)664 M(302 M)(684 M)(99 M)600 M655 M(200 M)(500 M)2.3 B(70 M)(71.8 M)
VZ175 M6.7 B(10.3 B)50.4 B(42.9 B)(6.1 B)(1.6 B)(1.6 B)(1.6 B)(1.6 B)(1.6 B)(1.8 B)(1.9 B)
CAT(535 M)(535 M)2.4 B591 M1.3 B(881 M)688 M1.1 B(430 M)402 M1.1 B(103 M)(105.7 M)
PFE(144 M)1.4 B6.9 B(7.9 B)1.2 B298 M(1 B)(1.2 B)(205 M)125 M125 M112.5 M121.4 M
AA65 M65 M65 M65 M53 M291 M302 M506 M(249 M)(233 M)727 M314 M279.5 M

Healthequity and related stocks such as La-Z-Boy, Chevron Corp, Home Depot, JP Morgan Chase, 3M Company, Verizon Communications, Caterpillar, Pfizer Inc, and Alcoa Corp Net Cash Flow or Change in Cash and Cash Equivalents description

Principal component of the cash flow statement representing the amount of increase (decrease) in cash and cash equivalents. Includes Net Cash Flow from Operations; investing Net Cash Flow from Investing and financing Net Cash Flow from Financing for continuing and discontinued operations; and the effect of exchange rate changes on cash [NCFX].

My Equities

My Current Equities and Potential Positions

AMN - USA Stock
Amn Healthcare Services
AMN
Amn Healthcare Fama & French Business Services
Business Services
Fama & French Classification
RegionNorth America
ExchangeNew York Stock Exchange
USD 113.8
Please check Healthequity Performance and Healthequity Correlation. Note that the Healthequity information on this page should be used as a complementary analysis to other Healthequity's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Analyst Recommendations module to analyst recommendations and target price estimates broken down by several categories.

Complementary Tools for Healthequity Stock analysis

When running Healthequity price analysis, check to measure Healthequity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Healthequity is operating at the current time. Most of Healthequity's value examination focuses on studying past and present price action to predict the probability of Healthequity's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Healthequity's price. Additionally, you may evaluate how the addition of Healthequity to your portfolios can decrease your overall portfolio volatility.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Is Healthequity's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Healthequity. If investors know Healthequity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Healthequity listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
-0.96
Market Capitalization
5.2 B
Quarterly Revenue Growth YOY
0.12
Return On Assets
0.0059
Return On Equity
-0.0299
The market value of Healthequity is measured differently than its book value, which is the value of Healthequity that is recorded on the company's balance sheet. Investors also form their own opinion of Healthequity's value that differs from its market value or its book value, called intrinsic value, which is Healthequity's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Healthequity's market value can be influenced by many factors that don't directly affect Healthequity's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Healthequity's value and its price as these two are different measures arrived at by different means. Investors typically determine Healthequity value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Healthequity's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.